Baiyunshan serves up high dividend in lieu of vanilla results
Profits from the company’s Great Health segment rose 14% in the first half of 2025, primarily driven by strong results for its popular Wanglaoji herbal tea Key Takeaways: Baiyunshan’s revenue…
Neautus looks outward to boost its traditional medicine story
The maker of traditional Chinese medicines has applied for a Hong Kong IPO after abandoning two listing attempts on China’s domestic A-share market Key Takeaways: Neautus has applied to list…
Recent Articles
RELATED ARTICLES
-
From ‘magic tea’ to dietary drugs, can Besunyen reclaim its glory days？
0926.HK - Its Hong Kong listing advancing, will investors drink up Bama Tea shares?
-
Red Bull slayer Eastroc chases Hong Kong IPO to boost global charge
605499.SHG
- Forget the pearls and cheese, Chagee says, offering up simpler milk teas for U.S. investors
- Xiao Noodles serves up IPO plan to take its tangy taste global
- Neautus looks outward to boost its traditional medicine story
-
Shiyue Daotian serves up tasty dividends as profits surge
9676.HK
